Abstract:Non-typhoidal Salmonella enterica strains, including serovar Typhimurium (STm), are an emerging cause of invasive disease among children and the immunocompromised, especially in regions of sub-Saharan Africa. STm invades the intestinal mucosa through Peyer's patch tissues before disseminating systemically. While vaccine development efforts are ongoing, the emergence of multidrug resistant strains of STm affirms the need to seek alternative strategies to protect high-risk individuals from infection. In this report, we investigated the potential of an orally administered O5 serotype-specific IgA monoclonal antibody (mAb), called Sal4, to prevent infection of invasive Salmonella enterica serovar Typhimurium (STm) in mice. Sal4 IgA was delivered to mice prior to or concurrently with STm challenge. Infectivity was measured as bacterial burden in Peyer's patch tissues one day after challenge. Using this model, we defined the minimal amount of Sal4 IgA required to significantly reduce STm uptake into Peyer's patches. The relative efficacy of Sal4 in dimeric and secretory IgA (SIgA) forms was compared. To assess the role of isotype in oral passive immunization, we engineered a recombinant IgG1 mAb carrying the Sal4 variable regions and evaluated its ability to block invasion of STm into epithelial cells in vitro and Peyer's patch tissues. Our results demonstrate the potential of orally administered monoclonal IgA and SIgA, but not IgG, to passively immunize against invasive Salmonella. Nonetheless, the prophylactic window of IgA/SIgA in the mouse was on the order of minutes, underscoring the need to develop formulations to protect mAbs in the gastric environment and to permit sustained release in the small intestine.The bacterium Salmonella enterica is responsible for significant morbidity and mortality in the developed and developing worlds. While the pathogen is most renowned as the causative agent of typhoid fever, the emergence of invasive non-typhoid strains like S. enterica serovar Typhimurium (STm) are of great concern because of their propensity to cause severe disease in children under the age of five. In this report, we demonstrate in a mouse model that oral administration of a monoclonal antibody targeting the surface of STm is able to prevent the bacterium from infecting gastrointestinal tissues, the first step in the dissemination process. We show that IgA antibodies (which are normally found in the gut) were far superior than an equivalent IgG antibody (normally found in blood) at defending the intestine from STm infection. These results lay the foundation for future studies aimed at the development of an orally administered antibody cocktail capable of providing temporary immunity to pathogens like S. enterica.

Chicken Egg Yolk Antibodies (igy) Modulate the Intestinal Mucosal Immune Response in a Mouse Model of Salmonella Typhimurium Infection

Transcriptomic and Proteomic Analysis of the Jejunum Revealed the Effects and Mechanism of Protocatechuic Acid on Alleviating Salmonella Typhimurium Infection in Chickens

Alteration in lymphocytes responses, cytokine and chemokine profiles in laying hens infected with Salmonella Typhimurium.

Chicken Egg Yolk Antibody (IgY) Protects Mice Against Enterotoxigenic Escherichia coli Infection Through Improving Intestinal Health and Immune Response

Chicken Egg Yolk Antibody (igy) Controls Solobacterium Moorei under in Vitro and in Vivo Conditions

Milk Fat Globule Membrane Attenuates Acute Salmonella Typhimurium Infection Induced Mouse Model of Colitis and Ameliorates Intestinal Immunity

Protective Effect of Bifidobacterium Lactis JYBR-190 on Intestinal Mucosal Damage in Chicks Infected with Salmonella Pullorum

Effect of chicken egg yolk antibodies (IgY) against diarrhea in domesticated animals: a systematic review and meta-analysis.

Small Intestinal Intraepithelial Lymphocytes Expressing Cd8 And T Cell Receptor Gamma Delta Are Involved In Bacterial Clearance During Salmonella Enterica Serovar Typhimurium Infection

The Outer Membrane Vesicles of Salmonella enterica Serovar Typhimurium Activate Chicken Immune Cells through Lipopolysaccharides and Membrane Proteins

Epigallocatechin gallate protects mice from Salmonella enterica ser. Typhimurium infection by modulating bacterial virulence through quorum sensing inhibition

Immunomodulatory Effects of Chicken Egg Yolk Antibodies (igy) Against Experimental Shewanella Marisflavi AP629 Infections in Sea Cucumbers (apostichopus Japonicus).

The Role of Egg Yolk in Modulating the Virulence of Salmonella Enterica Serovar Enteritidis

Effect of oral administration of microcin Y on growth performance, intestinal barrier function and gut microbiota of chicks challenged with Salmonella Pullorum

Modulation of Cytokine Gene Expression by Selected Lactobacillus Isolates in the Ileum, Caecal Tonsils and Spleen of Salmonella-challenged Broilers.

Transcriptional responses of cytokines, immunoglobulin A, and nitric oxide genes in 1-day-old chicks post Salmonella typhimurium infection: An experimental study

Evaluation of the prophylactic effect of egg yolk antibody (IgY) produced against the recombinant protein containing IpaD, IpaB, StxB, and VirG proteins from Shigella

Inhibition of the Type III Secretion System by Syringaldehyde Protects Mice from Salmonella Enterica Serovar Typhimurium

Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies

LGG promotes activation of intestinal ILC3 through TLR2 receptor and inhibits salmonella typhimurium infection in mice

Oral Treatment with Saccharomyces cerevisiae CNCM I-3856 Mitigates the Inflammatory Response Experimentally Induced by Salmonella enterica subsp. enterica Serovar Typhimurium in Mice